Article Text

Download PDFPDF
Review
The gut microbiome: what every gastroenterologist needs to know
  1. Benjamin H Mullish1,2,
  2. Mohammed Nabil Quraishi3,4,
  3. Jonathan P Segal2,
  4. Gianluca Ianiro5,
  5. Tariq H Iqbal3,4
  1. 1Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College of Science Technology and Medicine, London, UK
  2. 2Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK
  3. 3University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, UK
  4. 4Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  5. 5Digestive Disease Centre, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Gemelli, Rome, Italy
  1. Correspondence to Professor Tariq H Iqbal, Gastroenterology, University Hospital Birmingham NHS Trust, Birmingham B15 2TT, UK; t.h.iqbal{at}bham.ac.uk

Abstract

The mucosal surfaces of the body are characterised by complex, specialised microbial communities, often referred to as the microbiome. However, only much more recently—with the development of technologies allowing exploration of the composition and functionality of these communities—has meaningful research in this area become feasible. Over the past few years, there has been rapid growth in interest in the gut microbiome in particular, and its potential contribution to gastrointestinal and liver disease. This interest has already extended beyond clinicians to pharmaceutical companies, medical regulators and other stakeholders, and is high profile among patients and the lay public in general. Such expansion of knowledge holds the intriguing potential for translation into novel diagnostics and therapeutics; however, being such a nascent field, there remain many uncertainties, unanswered questions and areas of debate.

  • gut microbiome
  • faecal microbiota transplant
  • probiotics
  • Clostridioides difficile infection
  • inflammatory bowel disease
View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter @bhmullish, @nabilquraishi, @tariqfmt

  • Contributors BM, MNQ, JS, GI and THI all reviewed the literature and contributed to writing the manuscript.

  • Funding BHM is the recipient of a National Institute of Health Research (NIHR) Academic Clinical Lectureship. The Division of Digestive Diseases receives financial support from the NIHR Imperial Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.